Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Document Type
Year range
1.
Medicina Clinica Practica ; 5(2), 2022.
Article in English, Spanish | EMBASE | ID: covidwho-1587014

ABSTRACT

Introduction and objective: The SARS-CoV -2 epidemic represents a special risk for patients on hemodialysis (HD) due to their comorbidities and the fact that they often have a more severe case of inflammation with fewer symptoms and a worse evolution and outcome. The aim of this study was to detect the clinical and biochemical characteristics of patients on hemodialysis (HD) who presented a suspicious involvement of COVID-19 (Corona Virus Disease – 2019), their risk factors and specific outcomes. Material and methods: This is a retrospective, observational case report study in HD patients suspected of having COVID-19. Records pointed to comorbidities, clinical and laboratory tests, quantitative reverse transcription polymerase chain reaction (RT-qPCR) tests for SARS-COV -2 and outcomes. Descriptive statistics and linear and logistic regression analyses were performed. Results: Of the total number of HD patients (1514), 248 HD patients were suspected to have COVID-19 (106 were positive, 83 were negative and 59 suspected using PCR testing);the median age was 51 years (IR 36-63 years), 54.8% were males, had hypertension (87.5%), with a hemoglobin count of 8.9 g (IR 7.5-10.6 g) and symptoms such as cough, fever and dyspnea (65.7, 64.5 and 53.2%, respectively). The fatality rate in the group of patients with positive RT-qPCR was 29.24%. Conclusions: The mortality and fatality rate is often high in this population. The age group, sex, and cardio-metabolic comorbidities behave similarly to the rest of the non-renal population. Pre-existing biochemical status does not make a difference in the outcome. The predominant symptomatology was pulmonary in nature.

2.
Journal of Open Innovation: Technology, Market, and Complexity ; 7(2), 2021.
Article in English | Scopus | ID: covidwho-1259526

ABSTRACT

During such a complex crisis as the one experienced by humanity since the first quarter of 2020, it is necessary to develop tools that contribute to creating the corporate image for organizations that are currently interested in being identified as brands with high social and environmental commitment. Likewise, elements that contribute to building strong brands during a context that has changed consumption priorities are required. For this reason, this paper aims at adapting the dimension of socially responsible brand personality (SRBP), proposed by Mayorga (2017), taking the situation experienced due to the COVID-19 pandemic as a new context. The objective of this research is to contribute to the management of corporate social responsibility (CSR) by providing, from a communicative perspective, a tool that optimizes the creation of a socially responsible image by the different stakeholders. The results allow us to conclude that there is a structural modification of the brand personality proposed by Mayorga, which can be presumed to be generated by the current environment, and which, therefore, can be established as a pillar of CSR management in the new normal, from a relational point of view. The findings clearly identify the virtue of integrity in brand personality, which is made up of two attributes, which, in turn, are made up of 17 traits that can identify a socially responsible brand. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

SELECTION OF CITATIONS
SEARCH DETAIL